Covid19
Conditions
Brief summary
To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.
Detailed description
Communities Fighting COVID is a partnership between San Diego State's School of Public Health and numerous communities in San Diego focused on providing community-based testing to specific language-speaking communities and vulnerable populations. This partnership is funded by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics-Undeserved Populations (Radx-UP), with the aim of ensuring all Americans have access to timely COVID-19 testing and diagnosis. Many communities, particularly immigrant and people of color communities, have a harder time accessing existing COVID-19 resources due to transportation, language barriers, or other barriers.
Interventions
OTHERCOVID-19 Testing Home-based (Aim 1)
Implementation of Antigen and PCR testing at participant homes
OTHERCOVID-19 Testing Mobile (Aim 1)
Implementation of Antigen and PCR testing at mobile test sites
OTHERCOVID-19 Testing Mobile Approach 1 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - active outreach
OTHERCOVID-19 Testing Mobile Approach 2 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - baseline outreach
Sponsors
National Cancer Institute (NCI)
San Diego State University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
Cluster Randomized Trial
Eligibility
Sex/Gender
ALL
Age
6 Years to 120 Years
Healthy volunteers
Yes
Inclusion criteria
* African American, Arabic speaking, Filipino, and Latino/a populations
Exclusion criteria
* Younger than 6, not in focus populations
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Test uptake | Through study completion, expected to be 20 months | Testing volume by study arm as cumulative count per hours testing site operated |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Test access | Through study completion, expected to be 20 months | Proportion of individuals by study arm who note that this strategy has facilitated ability to test. |
| Test Impact (COVID-19 diagnoses) | Through study completion, expected to be 20 months | Proportion of COVID-19 diagnoses of those tested by study arm |
| Test Impact (number needed to screen) | Through study completion, expected to be 20 months | Number needed to screen (number tested in order to detect one new infection). |
Countries
United States
Outcome results
None listed